Annual, IR, Listing Regulation, News, Regulatory, Report, Swedish April 15, 2026 15 Apr 2026 Acarix AB’s Årsredovisning 2025 Acarix, ledande inom AI och avancerad akustikbaserad hjärtdiagnostik, meddelar idag att årsredovisning för 2025 finns t... Continue reading
Annual, English, IR, Listing Regulation, News, Regulatory, Report April 15, 2026 15 Apr 2026 Acarix AB’s Annual Report 2025 Acarix, a global leader in AI and advanced acoustic-based cardiac diagnostics, today announces that the Annual Report for 2025 is avail... Continue reading
Corporate Information, English, IR, News, Other Corporate Information April 7, 2026 07 Apr 2026 ACARIX PRESENTS ABSTRACT AT ACC.26 HIGHLIGHTING CADSCOR® SYSTEM’S DIAGNOSTIC UTILITY COMPARED TO STANDARD STRESS TESTS IN CHEST PAIN PATIENTS Findings demonstrate high NPV, care time savings of up to 40 hours, and cost reductions exceeding $100,000 per inpatient case, reinforc... Continue reading
English, Interim, IR, Listing Regulation, News, Regulatory, Report, Yearend February 12, 2026 12 Feb 2026 Acarix Publishes Year-End Report 2025 Malmö, Sweden – Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2025 year-end finan... Continue reading
Corporate Information, English, IR, News, Other Corporate Information February 11, 2026 11 Feb 2026 Acarix Announces New Distribution Partner in Saudi Arabia for the CADScor System Malmö, Sweden – Acarix AB (Nasdaq Stockholm: ACARIX), a medical device company advancing noninvasive, AI enabled diagnostics... Continue reading
Corporate Information, English, IR, News, Other Corporate Information February 4, 2026 04 Feb 2026 Acarix Receives EU MDR Certification for the CADScor®System Malmö, Sweden – Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announced that its CADScor Sys... Continue reading
Corporate Information, English, IR, MAR, News, Other Corporate Information, Regulatory December 8, 2025 08 Dec 2025 ACARIX CARRIES OUT A DIRECTED SHARE ISSUE OF APPROX. SEK 33.4 MILLION The Board of Directors of Acarix AB (publ) ("Acarix" or the "Company") has today resolved to carry out a directed share issue of maximu... Continue reading
Corporate Information, IR, MAR, News, Other Corporate Information, Regulatory, Swedish December 8, 2025 08 Dec 2025 ACARIX GENOMFÖR EN RIKTAD EMISSION OM CIRKA 33,4 MSEK Styrelsen i Acarix AB (publ) (”Acarix” eller ”Bolaget”) har idag beslutat om att genomföra en riktad nyemi... Continue reading
Corporate Information, English, IR, News, Other Corporate Information November 6, 2025 06 Nov 2025 Invitation to presentation of Acarix´s third quarter 2025 report Acarix third quarter result is now released and we invite investors, analysts, and media representatives to join the recorded webcast p... Continue reading
Interim, IR, Listing Regulation, News, Q3, Regulatory, Report, Swedish November 6, 2025 06 Nov 2025 Acarix AB (publ) publicerar tredje kvartalet 2025 Malmö, – Acarix, ledande inom akustisk- och algoritmbaserad hjärtdiagnostik, redovisade idag sina finansiella resultat ... Continue reading
English, Interim, IR, Listing Regulation, News, Q3, Regulatory, Report November 6, 2025 06 Nov 2025 Acarix Publishes Interim Report, Third quarter 2025 Malmö, Sweden – Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial ... Continue reading
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish October 27, 2025 27 Oct 2025 Kommuniké från extra bolagsstämma i Acarix AB Extra bolagsstämma i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 27 oktober 2025 varvid aktieägarna fattade besl... Continue reading